We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $645B
1-Year Est. Return 30.41%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+30.41%
3 Year Est. Return
+111.06%
5 Year Est. Return
+151.95%
10 Year Est. Return
+612.73%
AUM
$290B
AUM Growth
-$2.16B
Cap. Flow
-$4.46B
Cap. Flow %
-1.54%
Top 10 Hldgs %
23.52%
Holding
454
New
18
Increased
121
Reduced
127
Closed
24

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$1.43B
2
BA icon
Boeing
BA
+$1.39B
3
PRGO icon
Perrigo
PRGO
+$1.11B
4
MCK icon
McKesson
MCK
+$960M
5
JNPR
Juniper Networks
JNPR
+$825M

Sector Composition

Rank Sector Weight
1 Healthcare 18.47%
2 Technology 12.22%
3 Communication Services 12.18%
4 Industrials 10.66%
5 Consumer Staples 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$222B
$13.4B 4.61%
89,275,508
-2,685,500
-3% -$399M
VZ icon
2
Verizon
VZ
$196B
$9.08B 3.13%
167,895,205
-9,088,272
-5% -$455M
PM icon
3
Philip Morris
PM
$295B
$8.19B 2.82%
83,464,518
+821,405
+1% +$75.3M
ORCL icon
4
Oracle
ORCL
$423B
$6.71B 2.31%
164,104,290
-3,662,000
-2% -$136M
AMZN icon
5
Amazon
AMZN
$2.96T
$6.51B 2.24%
219,315,480
+12,536,760
+6% +$356M
MO icon
6
Altria Group
MO
$114B
$5.07B 1.75%
80,863,305
-5,650,000
-7% -$342M
NFLX icon
7
Netflix
NFLX
$309B
$5.03B 1.73%
492,064,770
+145,926,480
+42% +$1.43B
TXN icon
8
Texas Instruments
TXN
$261B
$4.8B 1.66%
83,634,017
-4,454,500
-5% -$236M
UNP icon
9
Union Pacific
UNP
$174B
$4.59B 1.58%
57,649,872
+240,061
+0.4% +$18.6M
ABBV icon
10
AbbVie
ABBV
$435B
$4.35B 1.5%
76,125,659
-1,443,000
-2% -$80.4M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$3.84B 1.32%
27,602,207
UNH icon
12
UnitedHealth
UNH
$370B
$3.73B 1.29%
28,971,178
+1,013,065
+4% +$120M
T icon
13
AT&T
T
$163B
$3.65B 1.26%
123,236,928
-13,722,196
-10% -$380M
ACN icon
14
Accenture
ACN
$108B
$3.54B 1.22%
30,706,943
-3,356,960
-10% -$345M
KO icon
15
Coca-Cola
KO
$375B
$3.53B 1.22%
75,989,374
+6,681,500
+10% +$291M
CNQ icon
16
Canadian Natural Resources
CNQ
$93.8B
$3.45B 1.19%
263,571,407
+42,404,955
+19% +$452M
SYK icon
17
Stryker
SYK
$130B
$3.42B 1.18%
31,885,233
-81,000
-0.3% -$7.98M
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.32T
$3.24B 1.12%
87,054,440
-71,558,140
-45% -$2.56B
GD icon
19
General Dynamics
GD
$106B
$3.2B 1.1%
24,395,204
-80,000
-0.3% -$10.6M
INTC icon
20
Intel
INTC
$513B
$3.18B 1.1%
98,384,500
-23,809,300
-19% -$731M
AIG icon
21
American International
AIG
$41.3B
$3.05B 1.05%
56,342,085
+5,811,400
+12% +$314M
EOG icon
22
EOG Resources
EOG
$70.7B
$3.03B 1.04%
41,727,587
+6,397,287
+18% +$442M
GE icon
23
GE Aerospace
GE
$384B
$2.94B 1.01%
19,298,444
-31,299
-0.2% -$4.42M
GILD icon
24
Gilead Sciences
GILD
$165B
$2.86B 0.99%
31,115,827
-22,012,580
-41% -$1.99B
MDT icon
25
Medtronic
MDT
$112B
$2.79B 0.96%
37,147,000
-338,000
-0.9% -$25.5M

Similar funds

Capital Research Global Investors's Q1 2016 Portfolio in Review

As of Q1 2016, Capital Research Global Investors held 454 positions worth $290B, down 0.74% from $292B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Research Global Investors's Q1 2016 filing shows 18 new, 121 increased, 127 reduced and 24 closed positions. Its largest new stake was Perrigo: 8,089,200 shares worth $1.03B. The largest sale was Alphabet (Google) Class C, an estimated $2.56B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.

  • Capital Research Global Investors's largest Q1 2016 buy was Perrigo: 8,089,200 shares worth $1.03B.
  • Capital Research Global Investors added most to Netflix in Q1 2016, an estimated $1.43B increase.
  • Capital Research Global Investors's biggest Q1 2016 reduction was Alphabet (Google) Class C, cutting an estimated $2.56B.
  • Capital Research Global Investors fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $2.21B.
  • Capital Research Global Investors's ten largest holdings make up 24% of its $290B portfolio in Q1 2016.
  • Capital Research Global Investors opened 18 new positions and closed 24 in Q1 2016.
  • Capital Research Global Investors's portfolio value fell 0.74% quarter-over-quarter to $290B.

Based on Capital Research Global Investors's 13F filing for Q1 2016, filed 16 May 2016.